Safety of fruquintinib in young and late-elderly Chinese patients with colorectal cancer in real-world clinical practice: Age subgroup analysis of a fruquintinib phase IV study. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback